Filter by
 

Origin

Publication date

Category

Main subject

Main subject

Keywords

Keywords

Geographical scope

Document language

EMCDDA Document Library

Displaying 1 - 10 of 11

Luxembourg national drug report 2020

April 2021

This report presents an overview of the drug phenomenon in Luxembourg, covering drug policy, drug supply and demand, drug use patterns, health consequences and responses, as well as drug markets and crime. The statistical data and analysis presented in this report relate to 2019 or the most recent...

Impact of COVID-19 on consumer practices and the use of specialised offers by high-risk drug users in the Grand Duchy of Luxembourg: findings from a quantitative study

January 2021

This study analyses the results of a survey conducted among a sample of 120 high risk drug users in Luxembourg and the impact of the COVID-19 pandemic. The survey included questons on the impact of the pandemic on their consumption habits, access to services, living conditions, emotonial aspects...

Continuity and change: high-risk drug use and drug treatment in Europe 2014

December 2014

Meeting proceedings include the programme, summaries of all sessions and abstracts of presentations presented during the EMCDDA event incorporating the Treatment Demand and High-Risk Drug Use/Problem Drug Use key epidemiological indicators expert meetings. This meeting took place from the 23 to 26...

Project to explore potential approaches to missing data on problem drug use in EU27 and Norway, including interpolation and / or qualitative information based on available estimates and other routinely collected data

June 2013

This report outlines the results of a small study that sought to examine whether interpolation methods, such as regression models, can be used to provide PDU prevalence estimates for years where prevalence estimates are not readily available. The aims of the study were to explore routinely...

Estimating the prevalence of drug injection using a multiplier method based on a register of new HIV diagnoses

June 2010

This scientific article was one of the 2011 EMCDDA scientific award winners, which celebrates scientific writing and distinguishes high-quality research in the field of illicit drugs.

HIV among injecting drug users in Europe: increasing trends in the East

December 2008

The human immunodeficiency virus (HIV) epidemic among injecting drug users (IDUs) shows different developments in different parts of the European region. In the countries of the European Union (EU) and the European Free Trade Association (EFTA), the rates of reported newly diagnosed cases of HIV...

Rapid Assessment and Response Methods

February 2004

The RAR is a set of different qualitative tools (observation and discussion grids, as well as structured /semi-structured questionnaires and estimation techniqes). RAR helps to get fast information on cultural interpretations and meanings, on viewpoints of communities, and on needs of vulnerable...

PDU (Problem drug use) revision summary

February 2003

This document is a summary of the concepts and definitions in the revised area. The changes are, for the most part, related to the theoretical component of the indicator. Data collection recommendations will remain mostly unchanged, with two exceptions: the addition of intensive cannabis use data...

European Network to Develop Policy Relevant Models and Socio-Economic Analyses of Drug Use, Consequences and Interventions Final report: Part 2 – Prevalence of problem drug use at the national level

January 2002

The basic objective of the project work was to explore and to develop the multivariate indicator method. The method introduced by Person, Retka and Woodward (1977, 1978) and modified by Mariani (1999) estimates drug use by combining several population-standardized indicators directly...

European Network to Develop Policy Relevant Models and Socio-Economic Analyses of Drug Use, Consequences and Interventions Final report: Part 4 – Time trends and incidence of problem drug use

January 2002

In the 1st 12-month period Kaplan Meyer and Cox Regression models were used to estimate the latency time between first drug use and first treatment. The group applied a Back-Calculation Model to estimate the incidence of problem drug use from the observed incidence in treatment, using the latency...

Loading